Plakous Therapeutics has a total of 31 patents globally, out of which 11 have been granted. Of these 31 patents, more than 87% patents are active. The United States of America is where Plakous Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Plakous Therapeutics.
Plakous Therapeutics was founded in 2016. As an innovative human biologics firm, the company’s objective is to use regenerative biotherapeutics to assist patients overcome inflammation-driven disorders from infancy to old age.
Do read about some of the most popular patents of Plakous Therapeutics which have been covered by us in this article and also you can find Plakous Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Plakous Therapeutics patent portfolio.
How many patents does Plakous Therapeutics have?
Plakous Therapeutics has a total of 31 patents globally. These patents belong to 4 unique patent families. Out of 31 patents, 27 patents are active.
How Many Patents did Plakous Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Plakous Therapeutics Applications Filed | Plakous Therapeutics Patents Granted |
| 2023 | – | 1 |
| 2022 | 5 | 6 |
| 2021 | 1 | 4 |
| 2020 | 7 | – |
| 2018 | 3 | – |
| 2017 | 15 | – |
How many Plakous Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Plakous Therapeutics File in Different Countries?
Countries in which Plakous Therapeutics Filed Patents
| Country | Patent |
| United States Of America | 4 |
| China | 3 |
| Japan | 3 |
| Australia | 3 |
| Europe | 3 |
| Canada | 2 |
| India | 2 |
| Austria | 1 |
| Germany | 1 |
| Poland | 1 |
| Denmark | 1 |
| Spain | 1 |
| Italy | 1 |
Where are Research Centers of Plakous Therapeutics Patents Located?
The Research Center of Plakous Therapeutics is located in United States of America.
Best Plakous Therapeutics Patent
US20200239836A1 is the most popular patent in the Plakous Therapeutics portfolio. It has received 2 citations so far from companies like THT Biomaterials GmbH and 42Bio.
What Percentage of Plakous Therapeutics US Patent Applications Were Granted?
Plakous Therapeutics (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Plakous Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Plakous Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Kilpatrick Townsend & Stockton Llp Winston Salem | 4 | 100% |
List of Plakous Therapeutics patents
| Plakous Therapeutics Patents | Title |
| US11806370B2 | Methods Of Preparing And Using Placental Tissue Compositions |
| US10960028B2 | Placental Tissue Compositions |
| US20220401495A1 | Acellular Placental Therapies For Necrotizing Enterocolitis |
| US20200239836A1 | Acellular Placental Preparations |
| EP3429689B1 | Acellular Placental Preparations |
| EP4065143A1 | Acellular Placental Therapies For Necrotizing Enterocolitis |
| EP4008400A1 | Acellular Placental Preparations |
| CN109069867B | Acellular Placenta Preparation |
| CN114980909A | Cell-Free Placental Treatment For Necrotizing Enterocolitis |
| CN114404454A | Cell-Free Placental Formulations |
| WO2023038924A1 | Acellular Placental Therapies |
| WO2023038974A1 | Acellular Placental Therapies |
| ES2907751T3 | Acellular Placental Preparations |
| PL3429689T3 | Acellular Placental Preparations |
| DK3429689T3 | Acellular Placental Preparations |
| DE602017051279T2 | Acellular Placental Preparations |
| IT202200014840T2 | Acellular Placentary Preparations |
| JP7050692B2 | Cell-Free Placental Preparation |
| AU2017235220B2 | Acellular Placental Preparations |
| JP2023503973A5 | Cell-Free Placenta Therapy For Necrotizing Enterocolitis |
| JP2022101565A | Cell-Free Placenta Preparation |
| AU2022204044A1 | Acellular Placental Preparations |
| AU2020394215A1 | Acellular Placental Therapies For Necrotizing Enterocolitis |
| IN202217032612A | Acellular Placental Therapies For Necrotizing Enterocolitis |
| CA3157937A1 | Acellular Placental Therapies For Necrotizing Enterocolitis |
| IN201817034213A | Acellular Placental Preparations |
| CA3016606A1 | Acellular Placental Preparations |
| WO2021108748A1 | Acellular Placental Therapies For Necrotizing Enterocolitis |
| WO2018144694A1 | Placental Tissue Compositions |
| WO2017160804A1 | Acellular Placental Preparations |
| AT1456628T | Acellular Placenta Preparations |
What are Plakous Therapeutics key innovation segments?
What Technologies are Covered by Plakous Therapeutics?
The chart below distributes patents filed by Plakous Therapeutics